Sven Erickson will join the BioArctic on March 1 as Head of Medical Affairs. Sven has until now held the role of Medical Lead Alzheimer's Disease at Biogen Sweden and has previously worked at companies such as Roche, Novartis, Medivir and Isofol AB. He holds a PhD in experimental oncology from Karolinska Institutet.

Mats Ekelund assumes the role of Head of Market Access and will join the company on March 8. He joins the company from Biogen, where he was Head of Value & Access in the Nordics. He has previously worked at Wyeth and Pfizer. Mats holds a PhD in Economics from Stockholm School of Economics.

Harald Borgeke starts his position as Head of Public Affairs at the end of April. He has extensive experience in various commercial and market access roles from MSD, Novo Nordisk, Lilly and Celgene and currently works as Health Technology Assessment & Health Economics and Outcomes Reach Lead CAR-T at Bristol-Myers Squibb in the Nordics. Harald holds a Master's degree in Business Administration from Gothenburg School of Economics as well an MBA.

The department is also strengthened by the appointment of Professor Hans Basun as Senior Advisor Medical Affairs. Hans Basun has extensive clinical experience in patients with Alzheimer's disease and has previously held positions as Senior Director Clinical Development and Chief Medical Officer at BioArctic. Prior to joining BioArctic, Hans Basun has held senior positions at AstraZeneca.